IGC Pharma Inc (IGC)

IGC Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.41	3.55	11.44	17.78	8.3
Short-Term Investments	0	0.15	0	0.08	5.08
Cash & Cash Equivalents	1.41	3.71	11.44	17.86	13.38
Cash Growth	-62.08%	-67.58%	-35.97%	33.52%	-49.30%
Receivables	0.04	0.11	0.13	0.18	0.13
Inventory	1.54	2.65	3.55	5.48	4.25
Other Current Assets	0.72	0	0	0	0
Total Current Assets	3.71	6.47	15.11	23.52	17.76
Property, Plant & Equipment	3.89	8.54	9.87	11.33	10.35
Long-Term Investments	0	0	0	0.01	0.01
Goodwill and Intangibles	1.62	1.17	0.92	0.41	0.25
Other Long-Term Assets	0.69	1	0.94	0.6	0.61
Total Long-Term Assets	6.2	10.71	11.72	12.35	11.23
Total Assets	9.9	17.18	26.83	35.87	28.98
Accounts Payable	0.77	0.53	0.98	0.48	0.76
Current Debt	0	0	0	0.3	0.05
Other Current Liabilities	1.57	1.37	1.46	1.59	1.13
Total Current Liabilities	2.34	1.9	2.44	2.37	1.95
Long-Term Debt	0.22	0.35	0.49	0.68	0.49
Other Long-Term Liabilities	0.02	0.02	0.02	0.02	0.02
Total Long-Term Liabilities	0.24	0.37	0.5	0.7	0.5
Total Liabilities	2.58	2.27	2.94	3.06	2.45
Total Debt	0.22	0.35	0.49	0.99	0.54
Debt Growth	-36.49%	-28.25%	-50.76%	84.11%	970.00%
Retained Earnings	-113.67	-100.67	-89.16	-74.14	-65.37
Comprehensive Income	-3.42	-3.39	-2.97	-2.77	-2.85
Shareholders' Equity	7.32	14.91	23.89	32.8	26.54
Net Cash / Debt	1.19	3.36	10.95	16.88	12.84
Net Cash / Debt Growth	-64.73%	-69.32%	-35.11%	31.42%	-51.24%
Net Cash Per Share	0.02	0.06	0.22	0.40	0.33
Working Capital	1.37	4.57	12.67	21.15	15.81
Book Value Per Share	0.12	0.28	0.48	0.78	0.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).